Angelika is a purpose driven physician scientist with over 20 years of drug development expertise at Novartis, Gilead, Genentech and Amgen currently serving as the Development Unit Head of Immunology at Novartis. She earned her MD/PhD from the University of Freiburg, Germany, conduced her postdoctoral research at The Scripps Research Institute in La Jolla and has been honored to serve as a panel member at the FDA JIA Registry and Osteoarthritis Drug Development Workshops